Literature DB >> 33065422

Pregnancy in axial spondyloarthropathy: A systematic review & meta-analysis.

Sinead Maguire1, Tom O'Dwyer2, David Mockler3, Finbar O'Shea4, Fiona Wilson5.   

Abstract

BACKGROUND: Axial spondyloarthropathy (axSpA) is an inflammatory arthritis which affects the sacroiliac joints and the spine. Many females affected are of childbearing age. Studies on effects of pregnancy on axSpA disease activity and medication use have been limited, with divergent conclusions.
OBJECTIVE: To review literature on axSpA in pregnancy to determine the effect of disease on pregnancy outcomes.
METHODS: A systematic review of case-control trials, observational studies, cross sectional studies and case series (n>5) on axSpA in pregnancy. EMBASE, Medline (OVID), CINAHL, Maternity and Infant Care (MIDIRS online), and Web of Science were searched for keywords. Two reviewers reviewed articles to determine suitability for inclusion. The Newcastle Ottawa Scale was used to assess risk of bias. Data extraction was performed using a standardized template to streamline data to allow comparison and meta-analysis.
RESULTS: Search strategy returned 884 records, 130 full text articles were assessed for eligibility. Eighteen studies with a total of 3,166 axSpA participants were eligible for inclusion. There was an increased prevalence of pre-eclampsia (OR 1.3, 95% CI 0.92-1.82) and IUGR (OR 1.17, 95% CI 0.26-5.17) and a statistically significant increase in cesarean sections (OR 1.85, 95% CI 1.46-2.30) in axSpA females, with an especially high prevalence of elective cesarean sections (OR 2.26, 95% CI 1.74, 2.93). There was a trend towards increased prevalence of fetal complications in axSpA pregnancies (LBW OR 1.47, 95% CI 0.98-2.21; SGA OR1.66, 95% CI 0.93-2.95; congenital abnormalities OR 1.34, 95% CI0.63-1.24; NICU admissions OR 1.55, 95% CI 0.96-2.51) which did not reach significance.
CONCLUSION: AxSpA females have an increased prevalence of cesarean sections compared to the general population. There is a trend towards increased prevalence of pre-eclampsia, IUGR and certain fetal complications. Ongoing development of national registries could help to better understand axSpA in pregnancy.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ankylosing spondylitis; Axial spondyloarthropathy; Pregnancy; Systematic review

Mesh:

Year:  2020        PMID: 33065422     DOI: 10.1016/j.semarthrit.2020.08.011

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  3 in total

1.  Maternal and infant outcomes in pregnancies of women with axial spondyloarthritis compared with matched controls: results from nationwide health insurance data.

Authors:  Imke Redeker; Anja Strangfeld; Johanna Callhoff; Ursula Marschall; Angela Zink; Xenofon Baraliakos
Journal:  RMD Open       Date:  2022-07

2.  Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohort.

Authors:  Katarina Dathe; Johanna Frank; Stephanie Padberg; Stefanie Hultzsch; Evelin Beck; Christof Schaefer
Journal:  BMC Pregnancy Childbirth       Date:  2022-08-26       Impact factor: 3.105

Review 3.  Sex-associated and gender-associated differences in the diagnosis and management of axial spondyloarthritis: addressing the unmet needs of female patients.

Authors:  Maria-Sole Chimenti; Rieke Alten; Maria-Antonieta D'Agostino; Elisa Gremese; Uta Kiltz; Ennio Lubrano; Mireia Moreno; Thao Pham; Roberta Ramonda; Francesca-Romana Spinelli; Chiara Perella; Laura Andreoli
Journal:  RMD Open       Date:  2021-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.